A Chinese sweetener company is moving into the hemp-derived CBD sector with plans to invest $60 million in a hemp processing facility in the... Global maker of natural sweeteners plans $60 million CBD investment

A Chinese sweetener company is moving into the hemp-derived CBD sector with plans to invest $60 million in a hemp processing facility in the Midwest.

Layn Corp., based in the Guangxi province of China and best known for its stevia and monk fruit ingredients, plans to extract CBD from hemp, according to Food Navigator-USA.

Layn says it will build a hemp extraction facility somewhere in the Midwest by late 2020.

The company plans to contract with hemp farmers in 2019, then work with universities to develop new hemp varieties rich in cannabinoids beyond CBD, Layn USA president Elaine Yu told Food Navigator-USA.

Yu said hemp-derived products are reminiscent of the stevia craze that started 10 years ago.

“Now it’s all about CBD, but more than 100 cannabinoids have been identified,” Yu said.

She cautioned that some in the current hemp-derived CBD industry are raising federal alarms.

“A lot of manufacturers in this market do not have a background in producing dietary ingredients and have no idea what they are doing,” Yu told Food Navigator-USA this week at the Institute of Food Technologists show in New Orleans.

Subscribe to our Newsletter

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )